Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

BackgroundDonor-specific anti-HLA antibodies (DSA) impact negatively on the outcome of intestinal grafts. Although the use of antibody-removal therapies (ART) is becoming more frequent in the last few years, issues regarding their timing and effectiveness remain under discussion.MethodsIn the presen...

Full description

Bibliographic Details
Main Authors: María Lasa-Lázaro, Esther Ramos-Boluda, Esther Mancebo, María José Castro-Panete, Rocío González-Sacristán, Javier Serradilla, Ane Miren Andrés-Moreno, Francisco Hernández-Oliveros, Estela Paz-Artal, Paloma Talayero
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
intestinal transplantation
multivisceral transplantation
donor-specific antibodies
antibody-removal therapies
pediatric transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1074577/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.1074577/full

Similar Items